Skip to main content

Table 2 Study assessments and time points

From: Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation

Study Assessments/Testing

Baseline

Day

-2

0

7

14

21

28

35

42

Next Clinic Visit

100

Demographics (patient-, disease-, and treatment-related)

X

          

Additional descriptive outcomes

   

X

X

X

X

   

X

Socioeconomic status

X

          

Hospital Anxiety and Depression Scale (HADS)

X

 

X

X

X

X

X

    

Blood draw for gene expression analysis

X

X

    

X

    

Pregnancy test for females of child bearing potential

X

          

Toxicity

  

X

X

X

X

X

Xa

Xa

  

Assessment of adherenceb

 

X

    

X

  

X

 

Heart rate and blood pressure

X

 

X

X

X

X

X

  

X

 

Myeloma response assessment

          

X

  1. aPropranolol group only
  2. bAdherence assessed weekly or monthly based on number of pills prescribed